- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04975646
Goal Attainment Scaling in Upper Limb Spasticity Treatment (GASBTX)
April 9, 2024 updated by: University Rehabilitation Institute, Republic of Slovenia
Goal Attainment Scaling in Upper Limb Spasticity Treatment With Botulinum Toxin and the Influence of Regular Exercise for Spastic Upper Limb on Quality of Life in Patients After Stroke
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study.
In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks.
In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Goal setting will be performed by the patient together with the physician according to the SMART principle (specific, measureable, achievable, realistic, time bound).
The goals will be classified according to the International Classification of Functioning, Disability and Health.
Goal attainment will be assessed using the Goal Attainment Scale - Light.
Comprehensive assessment of motor functioning will address range of motion, spasticity, pain, degree of motor disability and degree of dependence in daily activities.
The prescribed exercises for the test group will be passive or active, depending on spasticity of the impaired upper limb.
Both groups will keep an Exercise Diary during the second part of the study.
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Metka Moharić, MD, PhD
- Phone Number: +386 1 4758441
- Email: metka.moharic@ir-rs.si
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- University Rehabilitation Institute, Republic of Slovenia
-
Contact:
- Nataša Bizovičar, MD, PhD
- Phone Number: +386 1 4758351
- Email: natasa.bizovicar@ir-rs.si
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patient's or caregiver's approval
- ischemic or hemorrhagic stroke diagnosed using head CT/MRI
- at least one upper limb muscle spasticity (MAS ≥ 3)
- candidate for BTX-A treatment or already given BTX-A in the past
- patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points)
Exclusion Criteria:
- aphasic patients without caregiver's presence
- other neurological or musculoskeletal diseases that could affect the treatment outcome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test group
Prescribed exercise program
|
Active or passive exercises for the spastic upper limb, including functional electrical stimulation (FES), performed regularly for two weeks.
|
No Intervention: Control group
Exercising at patient's own discretion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
GAS-Light
Time Frame: At baseline, after 2 weeks (i.e., at the end of the 1st part of the study)
|
Change in Goal Attainment Scale - Light
|
At baseline, after 2 weeks (i.e., at the end of the 1st part of the study)
|
SQoL-6D
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in Spasticity Related Quality of Life Tool score
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ROM
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in Range of motion (degrees)
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
MAS
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in Modified Ashworth Scale score
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
PSFS
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Difference in Penn Spasm Frequency Scale
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
VAS
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in pain rating on the Visual Analog Scale
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
BSR
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in Brunnstrom Stage of Recovery score
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
MRS
Time Frame: Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Change in Modified Rankin Scale score
|
Start of the 2nd part of the study (i.e., after 2 weeks), end of the 2nd part of the study (i.e., after 4 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nataša Bizovičar, MD, PhD, University Rehabilitation Institute, Republic of Slovenia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2021
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
February 15, 2021
First Submitted That Met QC Criteria
July 14, 2021
First Posted (Actual)
July 23, 2021
Study Record Updates
Last Update Posted (Actual)
April 10, 2024
Last Update Submitted That Met QC Criteria
April 9, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Muscle Hypertonia
- Stroke
- Ischemic Stroke
- Muscle Spasticity
- Hemorrhagic Stroke
Other Study ID Numbers
- 202102
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Australia, Sweden, Canada, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, China, Greece, Japan, Turkey, Netherlands, Romania, United Kingdom, Portugal, Hungary, Italy, Brazil, France, S... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on Prescribed exercise program
-
Vanderbilt University Medical CenterCompletedBurnout, Professional | Burnout SyndromeUnited States
-
University College CorkCompleted
-
University of JaenCompleted
-
University of NottinghamBurdett Trust for Nursing; Nottinghamshire Healthcare NHS Trust; Nottingham City... and other collaboratorsCompleted
-
Royal College of Surgeons, IrelandRecruitingInflammatory Bowel DiseasesIreland
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingMild Traumatic Brain InjuryCanada
-
Mindmaze SATerminatedStroke | Motor DisordersGermany, Italy, United Kingdom
-
Azienda Sanitaria Locale CN1 CuneoNot yet recruiting
-
University of MiamiRecruiting